Page 21 - PCC10

EBiSC- European Bank for induced Pluripotent Stem Cells http://www.ebisc.org
• Project funded by the Innovative Medicines Initiative (IMI)
• Quality-controlled, disease-relevant, research- grade iPSC lines, data and cell services.
• Centralized, not-for-profit iPSC bank providing researchers across academia and industry.
• Robust, reliable supply chain from the generation of cell lines, to internationally accepted quality criteria and their world-wide distribution to any qualified user.
• Babraham Research Campus (Cambridge, UK) and Fraunhofer IBMT (Saarbrücken, Germany)
• Coordination by the European Cell Culture Collection (ECACC) of Public Health England
(Department of Health, UK)
PCC Stem Cells - ESHRE BCN 2018
The leading applications for pluripotent stem cell derivatives.
Differentiation
retinal pigment epithelium A9 dopaminergic neurons Oligodendrocytes pancreatic β-islet cells cardiomyocytes.
Trounson and Dewitt, 2016
Clinical trials
hESC derivatives:
for age-related macular degeneration (AMD) type I diabetes
spinal cord injury myocardial infarct Parkinson disease
hiPSC derivatives : AMD
PCC Stem Cells - ESHRE BCN 2018
Page 15 of 135
PRECONGRESS COURSE 10 I BARCELONA, SPAIN – 1 JULY 2018 21